Beijing Foyou Pharma CO.(SH:601089) Zhi Tong Cai Jing·2025-09-16 08:39Core Viewpoint - The company Fu Yuan Pharmaceutical (601089.SH) has received a drug registration certificate from the National Medical Products Administration for the production of Pioglitazone Metformin Tablets (15mg/850mg), marking a significant step in expanding its product offerings in the diabetes treatment market [1] Group 1: Product Approval - The National Medical Products Administration has issued a drug registration certificate for Pioglitazone Metformin Tablets (15mg/850mg) [1] - The original manufacturer of the drug is Takeda Pharmaceutical Company, which received approval for the product in the United States in August 2005 [1] - The drug is intended for use in combination with dietary control and exercise for type 2 diabetes patients who have inadequate blood sugar control with Metformin alone [1]